Citations

Showing 10 of 108152 citations.

A novel compound active against SARS-CoV-2 targeting uridylate-specific endoribonuclease (NendoU/NSP15): in silico and in vitro investigations
Kumar, Sumit , Gupta, Yash , Zak, Samantha E. , Upadhyay, Charu, Sharma, Neha , Herbert, Andrew S. , Durvasula, Ravi , Poonam, Poonam , Kempaiah, Prakasha , Rathi, Brijesh , Potemkin, Vladimir , Poonam , Rathi, Brijesh , Kempaiah, Prakasha , Gupta, Yash , Herbert, Andrew S. , Dye, John M.

Mayo Clinic

RSC Medicinal Chemistry | August 18, 2021 | Volume: 12 | Issue: 10 | Pages: 1757-1764

10.1039/d1md00202c | PMID 34778776 Get It

A novel hydroxyethylamine compound was synthesised that displayed biological potency against SARS-CoV-2.
Top‐100 Most‐Cited Sports‐Related Concussion Articles Focus on Symptomatology, Epidemiology, and Demographics
McQuivey, Kade S. , Moore, M. Lane , Hassebrock, Jeffrey D. , Moore, M Lane , Pollock, Jordan Riley , Patel, Karan A. , Chhabra, Anikar

Mayo Clinic

Arthroscopy, Sports Medicine, and Rehabilitation | August 18, 2021 | Volume: 3 | Issue: 6 | Pages: No page available

10.1016/j.asmr.2021.06.016 | PMID 34977610 Get It

Purpose To analyze the top‐100 cited articles on sports‐related concussions together with a bibliometric analysis to determine citations by year, level of evidence, study design, and several other factors related to the top referenced articles in sports concussions. Methods The Clarivate Analytics Web of Knowledge database was used to gather data using Boolean queries to capture all possible iterations of sports‐related concussion research. Articles were organized in descending order based on the number of citations and included or excluded based on relevance to concussion. Collected information included author name, publication year, country of origin, journal name, article type, study focus, and the level of evidence . Results The top‐100 articles were cited 31,197 times with an average of 312.0 citations per publication. More than one half were published in 2006 or later (52). Cohort studies and descriptive articles were the most prevalent study types (22 each). Studies with Level V evidence were the most common (33). The most common areas of study were symptomatology (short term, long term) with 17 articles, followed by epidemiology/demographics with 16 articles. The least common area of study was concussion prevention (2 articles), followed by management/treatment, diagnostics (labs, imaging) with 4 articles each. Conclusions We identified the most influential studies in sports‐related concussion based on number of citations and citation density. A majority of these articles were published in the United States after 2006 and are most commonly cohort studies (Level IV evidence) and descriptive articles (Level V evidence). Current research focuses most heavily on the symptomatology and epidemiology/demographics of sports concussion. Clinical Relevance This study serves to identify the most influential articles in sports‐related concussion and identify research topics with general deficiencies within the field of sports‐related concussion research.
The Majority of Complaints About Orthopedic Sports Surgeons on Yelp Are Nonclinical
Arthur, Jaymeson R. , Smith, Jacob F. , Mujahed, Tala , Brinkman, Joseph C. , Moore, M. Lane , Chhabra, Anikar , Moore, M Lane , Chhabra, Anikar , Pollock, Jordan Riley

Mayo Clinic

Arthroscopy, Sports Medicine, and Rehabilitation | August 18, 2021 | Volume: 3 | Issue: 5 | Pages: No page available

10.1016/j.asmr.2021.07.008 | PMID 34746847 Get It

Purpose To examine and characterize extremely negative Yelp reviews of orthopedic sports surgeons in the United States. Methods A search for reviews was performed using the keywords “Orthopedic Sports Medicine” on Yelp.com for 8 major metropolitan areas. Single‐star reviews were isolated for analysis, and individual complaints were then categorized as clinical or nonclinical. The reviews were classified as surgical or nonsurgical. Results A total of 11,033 reviews were surveyed. Of these, 1,045 (9.5%) were identified as 1‐star, and 289 were ultimately included in the study. These reviews encompassed 566 total complaints, 133 (23%) of which were clinical, and 433 (77%) of which were nonclinical in nature. The most common clinical complaints concerned complications (32 complaints; 6%), misdiagnosis (29 complaints; 5%), and uncontrolled pain (21 complaints; 4%). The most common nonclinical complaints concerned physicians’ bedside manner (120 complaints; 21%), unprofessional staff (98 complaints; 17%), and finances (78 complaints; 14%). Patients who had undergone surgery wrote 47 reviews that resulted in 114 complaints (20.5% of total complaints), whereas nonsurgical patients were responsible for 242 reviews and a total of 452 complaints (81.3% of total complaints). The difference in the number of complaints by patients after surgery and patients without surgery was statistically significant ( P < 0.05) for all categories except for uncontrolled pain, delay in care, bedside manner of midlevel staff, and facilities. Conclusion Our study of extremely negative Yelp reviews found that 77% of negative complaints were nonclinical in nature. The most common clinical complaints were complications, misdiagnoses and uncontrolled pain. Only 16% of 1‐star reviews were from surgical patients. Clinical Relevance Patients use online review platforms when choosing surgeons. A comprehensive understanding of factors affecting patient satisfaction and dissatisfaction is needed. The results of our study could be used to guide future quality‐improvement measures and to assist surgeons in maintaining favorable online reputations.
Supporting Children and Kinship Caregivers in the Context of Substance Use Disorder: Perspectives of Key Professionals
Tye, Jessica E. , Olsen, Gayle, Moore, Mitchell J., Aleman, Martha J., Chawla, V K, Tye, Jessica E. , Meiers, Sonja J.

Mayo Clinic

Journal of Family Issues | August 18, 2021 | Volume: 43 | Issue: 11 | Pages: 2986-3003

10.1177/0192513x211038067 Get It

One in eight children in the United States grows up in a household with parental substance use disorder (SUD). The purpose of this study was to explore the needs of children and kinship caregivers affected by SUD, as perceived by 23 professionals who interact with these families. A community-based participatory research approach with exploratory and descriptive qualitative methods was utilized. Results indicated that (a) children need relationships and connections, stability, emotional and health care support, and protection from risks associated with SUD; (b) caregivers need community resource and navigation supports, skills development, and understanding of the caregiver’s role; and (c) there is a lack of existing comprehensive resources and services to support families affected by SUD. This study adds to existing literature by identifying key professionals’ perceptions and examining various types of kin relationships. Future research and practice implications are discussed.
Reversible cerebral vasoconstriction syndrome developing after an erenumab injection for migraine prevention
Rozen, Todd D. , Bhatt, Alok A. , Bhatt, Alok A

Mayo Clinic

Cephalalgia | August 18, 2021 | Volume: 42 | Issue: 3 | Pages: 250-256

10.1177/03331024211037277 | PMID 34405713 Get It

Background Reversible cerebral vasoconstriction syndrome is normally triggered by vasoactive compounds or illicit drugs. A new type of migraine preventive medication blocks calcitonin gene-related peptide utilizing monoclonal antibodies. Calcitonin gene-related peptide is a potent vasodilator for the cerebrovascular system. Could blocking calcitonin gene-related peptide be a trigger for cerebral artery vasospasm in patients susceptible to developing reversible cerebral vasoconstriction syndrome (migraine patients) or in individuals using vasoactive compounds? We present a case of reversible cerebral vasoconstriction syndrome occurring after calcitonin gene-related peptide monoclonal antibody treatment. Case report A 43-year -old woman with a history of episodic migraine developed an acute headache with orgasm two days after taking her second injection of erenumab. Ten days after erenumab injection she developed a thunderclap headache while completing a high intensity workout. These new headaches were only left sided. Computed tomography angiography demonstrated mild to moderate areas of narrowing involving the left middle and anterior cerebral arteries, concerning for reversible cerebral vasoconstriction syndrome. She denied exposure to any known reversible cerebral vasoconstriction syndrome precipitant medication or illicit drugs. She did endorse recent exposure to high altitude prior to erenumab therapy. She was started on verapamil 40 mg three times per day and her headache ceased within 24 h of initiating treatment. A repeat CT angiogram completed 4 weeks after the initial study noted resolution of the areas of vessel stenosis. Conclusion A case of reversible cerebral vasoconstriction syndrome developing after treatment with a calcitonin gene-related peptide monoclonal antibody is presented. The timing of the new type of headache occurring 2 days post erenumab injection suggests a possible cause and effect relationship. Reversible cerebral vasoconstriction syndrome as a possible treatment-related complication to the usage of calcitonin gene-related peptide monoclonal antibodies needs to be studied further.
Real-World Efficacy and Safety of Multi-Tyrosine Kinase Inhibitors in Radioiodine Refractory Thyroid Cancer
Koehler, Viktoria Florentine , Berg, Elke, Adam, Pia , Weber, Gian-Luca, Pfestroff, Andreas , Luster, Markus , Kutsch, Jana Maria, Sandner, Benjamin, Rayes, Nada, Fuß, Carmina Teresa , Kreißl, Michael C. , Hoster, Eva , Allelein, Stephanie, Kroiß, Matthias , Spitzweg, Christine , glands, on behalf of the German Study Group for Rare Malignant Tumors of the Thyroid and Parathyroid, Kroiss, Matthias , Hoster, Eva , Lapa, Constantin , Schott, Matthias , Todica, Andrei S. , Fassnacht, Martin, glands, on behalf of the German Study Group for Rare Malignant Tumors of the Thyroid and Parathyroid

Mayo Clinic

Thyroid® | August 18, 2021 | Volume: 31 | Issue: 10 | Pages: 1531-1541

10.1089/thy.2021.0091 | PMID 34405734 Get It

Background: The management of patients with locally advanced or metastatic differentiated thyroid cancer (DTC) that is refractory to radioiodine (RAI) remains a therapeutic challenge. The multi-tyrosine kinase inhibitors (TKIs) sorafenib and lenvatinib have been approved based on phase 3 clinical trials. Patients and Methods: We aimed at describing the efficacy and safety of TKI treatment of RAI-refractory DTC in a real-world setting at six German referral centers. One hundred and one patients with locally advanced or metastatic RAI-refractory DTC treated with sorafenib, lenvatinib, and/or pazopanib were included. Progression-free survival (PFS) and overall survival (OS) probabilities were estimated by using the Kaplan-Meier method. Results: Ninety-seven of 101 patients had progressive disease before TKI initiation. The median PFS for first-line treatment with sorafenib ( n = 33), lenvatinib ( n = 53), and pazopanib ( n = 15) was 9 (95% confidence interval 5.2–12.8), 12 (4.4–19.6), and 12 months (4.4–19.6), respectively. The median OS for first-line treatment was 37 (10–64) for sorafenib, 47 (15.5–78.5) for lenvatinib, and 34 months (20.2–47.8) for pazopanib. Serious complications (e.g., hemorrhage, acute coronary syndrome, and thrombosis/venous thromboembolism) occurred in 16 out of 75 (21%) patients taking lenvatinib, in 3 out of 42 (7%) patients taking sorafenib, and in 3 out of 24 (13%) patients taking pazopanib. Conclusions: Sorafenib, lenvatinib, and pazopanib are effective treatment options in the majority of patients with RAI-refractory DTC. The PFS and six-month survival rate in patients treated with lenvatinib und pazopanib appear to compare favorably with sorafenib in the first-line treatment setting. However, a more advanced disease stage at treatment initiation in sorafenib- and pazopanib-treated patients in the era before TKI-approval and the retrospective nature of this study precludes a direct comparison of TKIs.
Cranial suture headache: An extracranial head pain syndrome originating in the cranial sutures of the skull
Rozen, Todd D.

Mayo Clinic

Cephalalgia Reports | August 18, 2021 | Volume: 4 | Issue: No issue available | Pages: No page available

10.1177/25158163211040072 Get It

Objective: To define a new type of head pain syndrome termed “cranial suture headache” which is a localized headache originating along the cranial suture lines of the skull. Background: Well localized headaches maybe extracranial in origin. As trigeminal nociceptors are localized within the cranial sutures of the skull, these fibrous joints maybe the source of head pain for some patients. Methods: Case series. To diagnose cranial suture headache, the patient’s pain had to be localized to the skull and elicited/mimicked by mild to moderate palpation over one or more distinct cranial suture lines. Results: Ten cases are presented. Most of the patients were women (9/10). The headache started daily from onset in all cases. Range of age of headache onset was 32–64 years. Headache was one sided, unless confined to the midline and typically lacked any migrainous and/or cranial autonomic symptoms. Most cranial suture headaches localized to either the sagittal, coronal or squamosal suture lines. Headache duration prior to diagnosis was on average 8.5 years. Triggering events: three began immediately after head trauma, two had very remote head trauma, one was post infectious, one was post craniotomy, while three patients had no known triggering event. All patients were treatment refractory failing at least three preventive medications. All improved with localized anesthetic injection to the suture line(s) and/or onabotulinum toxin A injection only to the cranial sutures. Discussion: Without the recognition of cranial suture-based pain, patients may have unremitting headaches that can last years to decades. The observation that “cranial suture” headache improves with localized treatment only to the cranial sutures would seem to suggest the extracranial origin of the pain.
Stress Echo 2030: The Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging
Pepi, Mauro , Ciampi, Quirino , Cortigiani, Lauro , Arruda‐Olson, Adelaide M. , Daros, Clarissa Borguezan , Pretto, José Luis de Castro e Silva , Bossone, Eduardo , Merli, Elisa , Kane, Garvan C. , Scali, Maria Chiara, Morrone, Doralisa , Simova, Iana , Samardjieva, Martina, Boshchenko, A , Ryabova, T. R. , Pálinkás, Eszter Dalma , Sepp, Róbert , Torres, Marco Antônio Rodrigues , Villarraga, Hector R. , Kovačević-Preradović, Tamara , Citro, Rodolfo , Amor, Miguel , Mosto, Hugo , Salamè, Michael, Leeson, Paul , Gaibazzi, Nicola , Tuttolomondo, Domenico , Prota, Costantina , Peteiro, Jesús , Heyning, Caroline M. Van De , D’Andrea, Antonello , Rigo, Fausto , Ostojić, Miodrag , Arbucci, Rosina , Haber, Diego M. Lowenstein, Merlo, Pablo , Wierzbowska‐Drabik, Karina , Kasprzak, Jarosław D. , Haberka, Maciej , Ratanasit, Nithima , Mori, Fabio , D’Alfonso, Maria Grazia , Tassetti, Luigi , Milazzo, Alessandra , Olivotto, Iacopo , Marchi, Alberto, Rodríguez‐Zanella, Hugo , Zagatina, A , Padang, Ratnasari , Dekleva, Milica , Djordievic-Dikic, Ana, Boskovic, N , Tešić, Milorad , Giga, Vojislav , Salvo, Giovanni Di , Lorenzoni, Valentina , Cameli, Matteo , Bombardini, Tonino, Caso, Pio, Čelutkienė, Jelena , Barbieri, Andréa , Benfari, Giovanni , Bartolacelli, Ylenia , Malagoli, Alessandro , Mantovani, Francesca , Villari, Bruno, Russo, Antonello , Nes, Michele De, Carpeggiani, Clara , Monte, Ines , Re, Federica , Cotrim, Carlos , Bilardo, G, Karužas, Arnas , Matuliauskas, D, Colonna, Paolo , Antonini‐Canterin, Francesco, Pellikka, Patricia A. , (SIECVI), The Stress Echo 2030 Study Group of the Italian Society of Echocardiography and Cardiovascular Imaging, Borguezan-Daros, Clarissa , de Castro E Silva Pretto, José Luis , Bossone, Eduardo , Morrone, Doralisa , Palinkas, Eszter Dalma , Preradović, Tamara Kovačević , Tuttolomondo, Domenico , Peteiro, Jesus , Van De Heyning, Caroline M , D'Andrea, Antonello , Arbucci, Rosina , Wierzbowska-Drabik, Karina , Tassetti, Luigi , Olivotto, Iacopo , Rodriguez-Zanella, Hugo , Tesic, Milorad , Di Salvo, Giovanni , Cameli, Matteo , Mandoli, Giulia Elena , Barbieri, Andrea , Benfari, Giovanni , Bartolacelli, Ylenia , Malagoli, Alessandro , Mantovani, Francesca , Monte, Ines , Cotrim, Carlos , Karuzas, Arnas , Colonna, Paolo , Pepi, Mauro , Pellikka, Patricia A , Ciampi, Quirino , Zagatina, Angela , Kasprzak, Jaroslaw D , Ryabova, Tamara , Gaibazzi, Nicola , Lorenzoni, Valentina , Citro, Rodolfo , Boshchenko, Alla , Celutkiene, Jelena , Cocchia, Rosangela , Varga, Albert , Ágoston, Gergely , Vrublevsky, A. V. , Pálinkás, Attila , Mangia, Cristina , Nikolic, Aleksandra, Lowenstein, Jorge , Camarozano, Ana Cristina , Marchi, Alberto, Beleslin, Branko , Bursi, Francesca , Saad, Ariel K. , (SIECVI), The Stress Echo 2030 Study Group of the Italian Society of Echocardiography and Cardiovascular Imaging

Mayo Clinic

Journal of Clinical Medicine | August 17, 2021 | Volume: 10 | Issue: 16 | Pages: 3641

10.3390/jcm10163641 | PMID 34441937 Get It

With stress echo (SE) 2020 study, a new standard of practice in stress imaging was developed and disseminated: the ABCDE protocol for functional testing within and beyond CAD. ABCDE protocol was the fruit of SE 2020, and is the seed of SE 2030, which is articulated in 12 projects: 1-SE in coronary artery disease (SECAD); 2-SE in diastolic heart failure (SEDIA); 3-SE in hypertrophic cardiomyopathy (SEHCA); 4-SE post-chest radiotherapy and chemotherapy (SERA); 5-Artificial intelligence SE evaluation (AI-SEE); 6-Environmental stress echocardiography and air pollution (ESTER); 7-SE in repaired Tetralogy of Fallot (SETOF); 8-SE in post-COVID-19 (SECOV); 9: Recovery by stress echo of conventionally unfit donor good hearts (RESURGE); 10-SE for mitral ischemic regurgitation (SEMIR); 11-SE in valvular heart disease (SEVA); 12-SE for coronary vasospasm (SESPASM). The study aims to recruit in the next 5 years (2021–2025) ≥10,000 patients followed for ≥5 years (up to 2030) from ≥20 quality-controlled laboratories from ≥10 countries. In this COVID-19 era of sustainable health care delivery, SE2030 will provide the evidence to finally recommend SE as the optimal and versatile imaging modality for functional testing anywhere, any time, and in any patient.
Sex-Specific Effects of Plastic Caging in Murine Viral Myocarditis
Bruno, Katelyn A. , Macomb, Logan P. , Morales-Lara, Andrea Carolina , Mathews, Jessica, Frisancho, J. Augusto, Yang, Alex Lingyun, Florio, Damian N. Di , Edenfield, Brandy , Whelan, Emily R. , Salomon, Gary R., Hill, Anneliese R., Hewa‐Rahinduwage, Chathuranga C., Scott, Ashley Jennie , Greyner, Henry, Molina, Frank, Greenaway, Merci S., Cooper, George , Fairweather, DeLisa , Morales-Lara, A Carolina, Mathews, Jessica E, Yang, Alex L, Di Florio, Damian N, Edenfield, Brandy H, Fairweather, DeLisa , Bruno, Katelyn A , Di Florio, Damian N , Cooper, George M.

Mayo Clinic

International Journal of Molecular Sciences | August 17, 2021 | Volume: 22 | Issue: 16 | Pages: 8834

10.3390/ijms22168834 | PMID 34445539 Get It

Background: Myocarditis is an inflammatory heart disease caused by viral infections that can lead to heart failure, and occurs more often in men than women. Since animal studies have shown that myocarditis is influenced by sex hormones, we hypothesized that endocrine disruptors, which interfere with natural hormones, may play a role in the progression of the disease. The human population is exposed to the endocrine disruptor bisphenol A (BPA) from plastics, such as water bottles and plastic food containers. Methods: Male and female adult BALB/c mice were housed in plastic versus glass caging, or exposed to BPA in drinking water versus control water. Myocarditis was induced with coxsackievirus B3 on day 0, and the endpoints were assessed on day 10 post infection. Results: We found that male BALB/c mice that were exposed to plastic caging had increased myocarditis due to complement activation and elevated numbers of macrophages and neutrophils, whereas females had elevated mast cell activation and fibrosis. Conclusions: These findings show that housing mice in traditional plastic caging increases viral myocarditis in males and females, but using sex-specific immune mechanisms.
A model of weight‐based stigma in health care and utilization outcomes: Evidence from the learning health systems network
Phelan, Sean M. , Haller, Irina V. , Schroeder, Darrell R. , Fischer, Kristin , Croghan, Ivana T. , Croghan, Ivana, Phelan, S M , Schroeder, Darrell , Bauer, Katherine W. , Bradley, David , Bradley, Steven M. , Mundi, Manpreet S. , Rutten, Lila J. Finney

Mayo Clinic

Obesity Science & Practice | August 17, 2021 | Volume: 8 | Issue: 2 | Pages: 139-146

10.1002/osp4.553 | PMID 35388341 Get It

AbstractObjectiveObesity is stigmatized and people with obesity report experiencing stigmatizing situations when seeking health care. The implications of these experiences are not well understood. This study tests an indirect effects model of negative care experiences as an intermediate variable between obesity and care avoidance/utilization and switching primary care doctors.MethodsA survey was completed by 2380 primary care patients in the Learning Health Systems Network (LHSNet) Clinical Data Research Network with a BMI >25 kg/m2. Measures included scales assessing stigmatizing situations, perceived patient‐centered communication, perceived respect, having delayed needed care, and having looked for a new primary doctor in the past 12 months. Sequential and serial indirect effects of care experiences and respect in the association between BMI and care utilization outcomes was modeled.ResultsThe hypothesized model was supported by findings. The associations between BMI and delaying needed care (OR = 1.06, p < 0.001) and attempting to switch primary doctors (OR = 1.02, p = 0.04) was mediated by both stigmatizing situations experienced in a health care context and lower patient‐centered communication. Lower perceived respect mediated the association between care experiences and utilization outcomes.ConclusionsPeople with higher BMIs may avoid care or switch doctors as a result of stigmatizing experiences and poor communication with doctors. These outcomes may contribute to morbidity in people with obesity if they delay or avoid care for health concerns when symptoms first present.